Laura Clague

Insider Reports History

Location
Escondido, CA
Signature
/s/ Laura Clague by Agnieszka Gallagher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Laura Clague:

Form 4 holding Director

Genasys Inc.

Security class
Common Stock
Shares / value
284,311
Estimated value
$525,975
Report date
27 Apr 2022
Price
$1.85
Ownership
Direct
Form 4 holding Chief Financial Officer

Travere Therapeutics, Inc.

Security class
Common Stock
Shares / value
35,655
Estimated value
$319,469
Report date
11 May 2022
Price
$8.96
Ownership
Direct
Form 4 holding Director

STANDARD BIOTOOLS INC.

Security class
Common Stock
Shares / value
104,791
Estimated value
$266,169
Report date
14 Jun 2023
Price
$2.54
Ownership
Direct
Form 4 holding Director

STANDARD BIOTOOLS INC.

Security class
Stock Option (Right to Buy)
Shares / value
35,380
Estimated value
$132,321
Report date
14 Jun 2023
Price
$3.74
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Genasys Inc.

Security class
Common Stock
Shares / value
2,000
Estimated value
$3,700
Report date
27 Apr 2022
Price
$1.85
Ownership
spouse
Form 4 holding Director

Genasys Inc.

Security class
Stock Option
Shares / value
0
Estimated value
Report date
27 Apr 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Laura Clague

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .